Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a ...

Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...

Malignant cutaneous melanoma is the most invasive and metastatic type of skin cancer. Surgical resection, the conventional ...

Recent research shows that tumors in different organs host microbial communities capable of influencing cancer biology, immune responses, and the effectiveness of therapies, highlighting the need to ...

Epicutis®, the professional skincare brand powered by patented biotechnology from Signum Biosciences, today announced the launch of Hydrobiome Serum ? a next-generation formulation that redefines how ...

It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same.

NIQ (the "Company", or "NIQ"), a leading global consumer intelligence company, plans to report its financial results for the first quarter ended March 31, 2026, on Thursday, May 14, 2026. The Company ...

Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced ...

Researchers suggest tunneling may reflect a conserved strategy adopted by specialized migratory cell types in dense tissues.

It is well known that students who prepare in advance perform better on exams. Now, it appears that the skin can do the same.Rather than scrambling to ...